Candel Therapeutics, Inc.
NASDAQ:CADLBiotechnology
Healthcare
$5.32 +0.56%
+$0.05 today
- Market cap
- $417.33M
- Beta
- -0.48
- P/E (TTM)
- -9.2
- EPS (TTM)
- -$0.87
52W Low $4.35High $9.57
Volume 1.39M
Average 1.82M
Price history
Candel Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+15.15%
Period high
$13.75
Period low
$4.42
Latest
$5.32
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 424B5 | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Nov 5, 2026 | Nov 5, 2026 | |
| 3 | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Sep 11, 2026 | Sep 11, 2026 | |
| 3 | Sep 10, 2026 | Sep 10, 2026 | |
| 8-K | Sep 10, 2026 | Sep 10, 2026 | |
| 4 | Sep 10, 2026 | Sep 10, 2026 | |
| 8-K | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 |
Competitors
Who does Candel Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about CADL's filings, answered from its disclosures.
What is the latest CADL filing?
The latest filing shown is 8-K dated Nov 12, 2026.
How many recent filings does CADL have?
Intrinsic Alpha currently shows 20 recent filings for CADL.
Continue the stock analysis
Jump to another research area for this company.